Education
About Us
Working with TipRanks
Follow Us
SkinBioTherapeutics PLC (GB:SBTX)
LSE:SBTX
SBTX Stock Chart & Stats
13.25p
-0.88p(-5.43%)
At close: 4:00 PM EST
13.25p
-0.88p(-5.43%)
Day’s Range― - ―
52-Week Range12.00p - 27.50p
Previous CloseN/A
Volume282.34K
Average Volume (3M)673.17K
Market Cap
£34.29M
Enterprise Value0.00p
Total Cash (Recent Filing)£4.78M
Total Debt (Recent Filing)£993.47K
Price to Earnings (P/E)―
Beta0.72
Next Earnings
Mar 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding258,779,450
10 Day Avg. Volume831,404
30 Day Avg. Volume673,172
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SkinBioTherapeutics News
SBTX FAQ
What was SkinBioTherapeutics PLC’s price range in the past 12 months?
SkinBioTherapeutics PLC lowest share price was 12.00p and its highest was 27.50p in the past 12 months.
What is SkinBioTherapeutics PLC’s market cap?
SkinBioTherapeutics PLC’s market cap is £34.29M.
When is SkinBioTherapeutics PLC’s upcoming earnings report date?
SkinBioTherapeutics PLC’s upcoming earnings report date is Mar 31, 2026 which is in 99 days.
How were SkinBioTherapeutics PLC’s earnings last quarter?
SkinBioTherapeutics PLC released its earnings results on Dec 05, 2025. The company reported 0.001p earnings per share for the quarter, beating the consensus estimate of N/A by 0.001p.
Is SkinBioTherapeutics PLC overvalued?
According to Wall Street analysts SkinBioTherapeutics PLC’s price is currently Overvalued.
Does SkinBioTherapeutics PLC pay dividends?
SkinBioTherapeutics PLC does not currently pay dividends.
What is SkinBioTherapeutics PLC’s EPS estimate?
SkinBioTherapeutics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SkinBioTherapeutics PLC have?
SkinBioTherapeutics PLC has 258,779,450 shares outstanding.
What happened to SkinBioTherapeutics PLC’s price movement after its last earnings report?
SkinBioTherapeutics PLC reported an EPS of 0.001p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -9.025%.
Which hedge fund is a major shareholder of SkinBioTherapeutics PLC?
Currently, no hedge funds are holding shares in GB:SBTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SkinBioTherapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.00%
12-Months-Change
Fundamentals
Return on Equity
-11.24%
Trailing 12-Months
Asset Growth
73.26%
Trailing 12-Months
Company Description
SkinBioTherapeutics PLC
SkinBioTherapeutics (SBTX) is a biotechnology company focused on developing innovative skincare products that harness the power of the skin microbiome. Operating in the health and beauty sector, SBTX aims to create products that not only enhance skin health but also address various dermatological issues. The company's core offerings include topical formulations designed to support skin barrier function and promote overall skin wellness, utilizing proprietary technology to extract and apply beneficial bacteria-derived ingredients.
Technical Analysis
Futura Medical
―
OptiBiotix Health
―
Sareum Holdings
―
Tissue Regenix
―
Ondine Biomedical, Inc.
―